Advertisement

Fate of Anabolic Steroids in the Body

  • Howard D. Colby
  • Penelope A. Longhurst

Abstract

The use of anabolic steroids in an attempt to enhance athletic performance has become a widespread practice in both amateur and professional sports in recent years. The rationale for such use (or abuse) of these agents is based upon the growth-promoting and musculature-developing, or anabolic, effects of the naturally occurring steroid hormones known as androgens. These are the hormones that play an important part in the sexual development of males, that is, the production of various masculine traits. The physiologically most important of the naturally occurring androgens is the hormone testosterone, which is produced principally by the testes. The anabolic steroids used by athletes are various synthetic derivatives of testosterone, substances with longer durations of action and/or greater potencies than the physiological androgens. Some of these compounds have been synthesized with the goal of enhancing the anabolic effects of testosterone relative to its masculinizing actions. Since these synthetic preparations are not native or endogenous to the body, they are classified as exogenous substances or drugs.

Keywords

Androgen Receptor Luteinizing Hormone Anabolic Steroid Hereditary Angioedema Luteinizing Hormone Secretion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hedge GA, Colby HD, Goodman RL (eds): Clinical Endocrine Physiology. Philadelphia, W. B. Saunders Co., 1987.Google Scholar
  2. 2.
    Eikelboom FA, van der Vies J (eds): Anabolics in the ‘80’s. Acta Endocrinol [Suppl] 271, 1985.Google Scholar
  3. 3.
    Kochakian CD (ed): Anabolic-Androgenic Steroids. Handbook of Experimental Pharmacology 43. Berlin, Springer Verlag, 1976.Google Scholar
  4. 4.
    Snyder PJ: Clinical use of androgens. Anna Rev Med 35: 207–217, 1984.CrossRefGoogle Scholar
  5. 5.
    Wilson JD, Griffin JE: The use and misuse of androgens. Metabolism 29: 1278–1295, 1980.PubMedCrossRefGoogle Scholar
  6. 6.
    Haupt HA, Rovere GD: Anabolic steroids: a review of the literature. Am J Sports Med 12: 469–484, 1984.PubMedCrossRefGoogle Scholar
  7. 7.
    Mainwaring WIP: The Mechanism of Action of Androgens. New York, Springer-Verlag, 1977.Google Scholar
  8. 8.
    Dürbeck HW, Büker I: Studies on anabolic steroids. The mass spectra of 17a-methyl-173-hydroxy1–1,4-androstadien-3-one (Dianabol) and its metabolites. Biomed Mass Spec 7: 437–445, 1980.CrossRefGoogle Scholar
  9. 9.
    MacDonald GS, Sykes PJ, Adhikary PM, et al: The identification of 17a-hydroxy-17-methyl-1,4androstadien-3-one as a metabolite of the anabolic steroid drug 173-hydroxy-17-methyl-1,4-androstadien-3-one in man. Steroids 18: 753–765, 1971.CrossRefGoogle Scholar
  10. 10.
    Steele RE, Didato F, Sawyer WK, et al: Evidence that 5a-reduction of M,3-ketosteroids may be more important for their androgenic than their luteinizing hormone-inhibiting activity. Endocrinology 105: 1026–1040, 1979.CrossRefGoogle Scholar
  11. 11.
    Wignand HP, Bosch AMG, Donker CW: Pharmacokinetic parameters of nandrolone (19-nortestosterone) after intramuscular administration of nandrolone decanoate (Deca-Durabolin) to healthy volunteers. Acta Endocrinol [Suppl] 271: 19–30, 1985.Google Scholar
  12. 12.
    Belkien L, Schürmeyer T, Hano R, et al: Pharmacokinetics of 19-nortestosterone esters in normal men. J Steroid Biochem 22: 623–629, 1985.PubMedCrossRefGoogle Scholar
  13. 13.
    Massé R, Laliberté C, Tremblay L, et al: Gas chromatographic/mass spectrometric analysis of 19nortestosterone urinary metabolites in man. Biomed Mass Spec 12: 115–121, 1985.CrossRefGoogle Scholar
  14. 14.
    Bergink EW, Janssen PSL, Turpijn EW, et al: Comparison of the receptor binding properties of nandrolone and testosterone under in vitro and in vivo conditions. J Steroid Biochem 22: 831–836, 1985.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1988

Authors and Affiliations

  • Howard D. Colby
    • 1
  • Penelope A. Longhurst
    • 1
  1. 1.Department of Biomedical SciencesUniversity of Illinois College of Medicine at RockfordRockfordUSA

Personalised recommendations